Outcome of melanoma patients with elevated LDH treated with first-line targeted therapy or PD-1-based immune checkpoint inhibition

Sarah Knispel, Maximilian Gassenmaier, Alexander M. Menzies, Carmen Loquai, Douglas B. Johnson, Cindy Franklin, Ralf Gutzmer, Jessica C. Hassel, Carsten Weishaupt, Thomas Eigentler, Bastian Schilling, Patrick Schummer, Judith Sirokay, Felix Kiecker, Carina N. Owen, Maria I. Fleischer, Christopher Cann, Katharina C. Kähler, Peter Mohr, Leonie BluhmDennis Niebel, Kai Martin Thoms, Simone M. Goldinger, Lydia Reinhardt, Friedegund Meier, Carola Berking, Raphael Reinhard, Laura Susok, Paolo A. Ascierto, Konstantin Drexler, Claudia Pföhler, Julia Tietze, Lucie Heinzerling, Elisabeth Livingstone, Selma Ugurel, Georgina V. Long, Andreas Stang, Dirk Schadendorf, Lisa Zimmer

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Outcome of melanoma patients with elevated LDH treated with first-line targeted therapy or PD-1-based immune checkpoint inhibition'. Together they form a unique fingerprint.

Medicine & Life Sciences